Paper32053786
Therapeutics Targeting the Gut Microbiome: Rigorous Pipelines for Drug Development.
Markey KA and 2 others. Cell Host Microbe, 2020. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Therapeutics Targeting the Gut Microbiome: Rigorous Pipelines for Drug Development. Papers, record 32053786. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32053786
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fecal Microbiota Transplantation | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Drug Development |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 AG052359 | NIA NIH HHS | United States | P01AG052359 | PubMed and NIH | NIH RePORTER |
| R01 HL123340 | NHLBI NIH HHS | United States | R01HL123340 | PubMed and NIH | NIH RePORTER |
| U01 AI124275 | NIAID NIH HHS | United States | U01AI124275 | PubMed and NIH | NIH RePORTER |
| R01 HL125571 | NHLBI NIH HHS | United States | R01HL125571 | PubMed and NIH | NIH RePORTER |
| R01 CA228358 | NCI NIH HHS | United States | R01CA228358 | PubMed and NIH | NIH RePORTER |
| R01 HL147584 | NHLBI NIH HHS | United States | R01HL147584 | PubMed and NIH | NIH RePORTER |
| K08 HL143189 | NHLBI NIH HHS | United States | K08HL143189 | PubMed and NIH | NIH RePORTER |
| P01CA023766 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 32053787 | Regulatory Considerations for Fecal Microbiota Transplantation Products. | https://conductscience.org/library/papers/32053787 |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42534583 | Gastrointestinal acute graft versus host disease: a translational perspective from pathogenesis to precision prevention and treatment. | Front Immunol | 2026 | https://conductscience.org/library/papers/42534583 | PubMed |
| 41978103 | Diet, the Gut Microbiome, and Estrogen Physiology: A Review in Menopausal Health and Interventions. | Nutrients | 2026 | https://conductscience.org/library/papers/41978103 | PubMed |
| 40212761 | Modelling Human Gut-Microbiome Interactions in a 3D Bioelectronic Platform. | Small Sci | 2024 | https://conductscience.org/library/papers/40212761 | PubMed |
| 39535493 | Wise Roles and Future Visionary Endeavors of Current Emperor: Advancing Dynamic Methods for Longitudinal Microbiome Meta-Omics Data in Personalized and Precision Medicine. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39535493 | PubMed |
| 39251833 | Semi-supervised meta-learning elucidates understudied molecular interactions. | Commun Biol | 2024 | https://conductscience.org/library/papers/39251833 | PubMed |
| 38694298 | Unlocking the gut-heart axis: exploring the role of gut microbiota in cardiovascular health and disease. | Ann Med Surg (Lond) | 2024 | https://conductscience.org/library/papers/38694298 | PubMed |
| 37871256 | Fecal Transplantation in Hematopoietic Transplantation. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/37871256 | PubMed |
| 35945640 | Developing whole cell standards for the microbiome field. | Microbiome | 2022 | https://conductscience.org/library/papers/35945640 | PubMed |
| 35327945 | Large-Scale Meta-Longitudinal Microbiome Data with a Known Batch Factor. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/35327945 | PubMed |
| 34721980 | Fecal microbiota transplantation mitigates bone loss by improving gut microbiome composition and gut barrier function in aged rats. | PeerJ | 2021 | https://conductscience.org/library/papers/34721980 | PubMed |
| 33709021 | Batch Culture Formulation of Live Biotherapeutic Products. | Adv Ther (Weinh) | 2021 | https://conductscience.org/library/papers/33709021 | PubMed |
| 33708214 | New Insights Into the Cancer-Microbiome-Immune Axis: Decrypting a Decade of Discoveries. | Front Immunol | 2021 | https://conductscience.org/library/papers/33708214 | PubMed |
| 33003084 | Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation. | Curr Opin Hematol | 2020 | https://conductscience.org/library/papers/33003084 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32053786
GET https://conductscience.org/api/papers/v1/32053786/authors